Zaiput Flow Technologies LLC SBIR Phase II award

National Science Foundation awarded Zaiput Flow Technologies LLC of Waltham, MA $1,250,000 under the SBIR program (Phase II), with work starting 2025-06-15 and running to 2027-05-31. It is one of 2 SBIR and STTR awards Zaiput Flow Technologies LLC received in the last two years, $1,556,301 in all. Each figure links to the federal record.

The award

Want the whole picture on Zaiput Flow Technologies LLC?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Zaiput Flow Technologies LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Zaiput Flow Technologies LLC covers

1. The Short Answer

2. Which Company This Is

3. What They Do, And How The Money Works

4. Who Runs It, And How To Reach Them

5. The Money: Funding, Valuation, Runway

6. Who Pays Them, And Who They Are Up Against

7. Warning Bells

8. Sources

   2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

Order Full ReportSee a sample report

A real finished report, first screen. Opens in a new tab.

What it is for

Continuous, scalable crystallizer for pharmaceutical manufacturing

Funding actions on this award

SBIR Phase II: Continuous, scalable crystallizer for pharmaceutical manufacturing -the broader impact/commercial potential of this small business innovation research (SBIR) project is to improve a key step used in the >$500-BILLION market of pharmaceutical manufacturing: Purification of active pharmaceutical ingredients (apis). 90% of all apis are purified using crystallization, however, the current, mainly batch-based, approaches available have drawbacks from both the commercial and scientific points of view. Current techniques are difficult to scale up, are expensive to maintain and manufacture, and are plagued by inconsistency and lack of uniformity in conditions and results. With the development and commercialization of the scalable continuous crystallizer technology proposed here, the company will address the scalability, cost, and inconsistency issues in order to: 1) speed up the transition to advanced manufacturing approaches (continuous manufacturing), 2) facilitate the re-shoring of drug manufacturing, contributing to addressing the national security challenge of american dependence on foreign drug manufacturers, and 3) reduce drug production costs, which will eventually lead to cheaper drugs for the benefit of the entire population. In summary, the commercialization of this technology may increase the adoption of advanced technologies, reduce national security risks, ...

From the federal award record.

Other SBIR and STTR awards to Zaiput Flow Technologies LLC

Where this comes from

The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs set aside part of federal research budgets for small companies. Agencies award them in phases: Phase I tests whether an idea is feasible, Phase II funds development, and Phase III is follow-on work paid for outside the set-aside. STTR awards also require a research institution as a partner.

Every figure on this page is taken from the award's own federal record, linked beside it, as it stood when the page was built: the recipient, its address, the awarding agency and office, the amount obligated so far, the dates and the description. Phase and program are shown as the award's own description states them. The amount can grow later if the agency adds funding to the same award.

All SBIR and STTR awards